Effect of GLP-1 receptor agonist, liraglutide, on muscle in spontaneously diabetic torii fatty rats
2022
Yamada, Shōhei | Ogura, Yūji | Inoue, Kazuho | Tanabe, Jun | Sugaya, Takeshi | Ohata, Keiichi | Nagai, Yoshio | Natsuki, Yasunori | Hoshino, Seiko | Watanabe, Shiika | Ichikawa, Daisuke | Kimura, Kenjirō | Shibagaki, Yūgo | Kamijo-Ikemori, Atsuko
This study investigated the effect of liraglutide, a glucagon-like peptide-1 receptor agonist, on skeletal muscles in rats with type 2 diabetes. Male SDT fatty rats (8-week-old) were provided liraglutide, or insulin-hydralazine for 8 weeks; control SDT fatty rats and SD rats were administered a vehicle. At 16 weeks of age, muscle strength of limbs was significantly lower in all SDT fatty rats compared to SD rats. While cross-sectional areas of type IIb muscle fibers in extensor digitorum longus muscle were significantly lower in SDT fatty rats than in SD rats, those of type I muscle fibers in soleus were similar in all rats. In the soleus of SDT fatty rats, liraglutide led to greater citrate synthase activity and cytochrome c oxidase subunit 5 B protein expression, independently of blood glucose and blood pressure levels. Liraglutide may contribute to preservation of mitochondrial content on soleus muscle in type 2 diabetes.
显示更多 [+] 显示较少 [-]